Document Detail


Patterns of use of insulin-sensitizing agents among diabetic, borderline diabetic and non-diabetic women in the National Health and Nutrition Examination Surveys.
MedLine Citation:
PMID:  23323803     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The purpose of this cross-sectional study based on the 2001-2006 National Health and Nutrition Examination Survey is to examine demographic, socioeconomic, lifestyle and reproductive characteristics that may distinguish users and non-users of insulin sensitizing agents among the US diabetic, borderline diabetic and non-diabetic women. Use of insulin-sensitizing agents was evaluated among 19,579 (3882 diabetic, 387 borderline diabetic and 15,310 non-diabetic) women. Overall, 2% of women in the study sample were users of insulin-sensitizers, including metformin, rosiglitazone and pioglitazone. Multivariate logistic regression models were constructed for predictors of insulin-sensitizer use according to diabetic status. In the overall sample, being younger or diabetic were the only factors associated with an increased odds of using insulin-sensitizing agents, after adjustment of confounders. Among diabetics, use of insulin-sensitizing agents was inversely related to age, but not other factors in the multivariable model. Among borderline and non-diabetics, body mass index (BMI) was the only predictor that remained significantly associated with the use of insulin-sensitizing agents after controlling for confounders. In conclusion, the main predictors of insulin-sensitizer use are young age and diabetic status in all women, young age in diabetic women and high BMI in borderline and non-diabetic women.
Authors:
Hind Beydoun; Vijaya Kancherla; Laurel Stadtmauer; May Beydoun
Related Documents :
19818843 - The antidiabetic plants tecoma stans (l.) juss. ex kunth (bignoniaceae) and teucrium cu...
3066353 - Fractionation of endocytic vesicles and glucose-transporter-containing vesicles in rat ...
19941833 - High glucose stimulates macrophage sr-bi expression and induces a switch in its activit...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Intramural     Date:  2013-01-17
Journal Detail:
Title:  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology     Volume:  29     ISSN:  1473-0766     ISO Abbreviation:  Gynecol. Endocrinol.     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-03-12     Completed Date:  2013-08-30     Revised Date:  2014-04-02    
Medline Journal Info:
Nlm Unique ID:  8807913     Medline TA:  Gynecol Endocrinol     Country:  England    
Other Details:
Languages:  eng     Pagination:  350-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Body Mass Index
Cross-Sectional Studies
Diabetes Mellitus, Type 2 / drug therapy*
Female
Humans
Hypoglycemic Agents / therapeutic use*
Insulin Resistance
Metformin / therapeutic use*
Middle Aged
Nutrition Surveys
Thiazolidinediones / therapeutic use*
United States
Grant Support
ID/Acronym/Agency:
Z99 AG999999/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Hypoglycemic Agents; 0/Thiazolidinediones; 122320-73-4/rosiglitazone; 9100L32L2N/Metformin; X4OV71U42S/pioglitazone
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A new compound from liquid fermentation broth of Armillaria mellea and the determination of its abso...
Next Document:  Exposure of Aspergillus fumigatus to caspofungin results in the release, and de novo biosynthesis, o...